Titan Spine raised US $7.5MM in Series D financing, alluded to in an earlier announcement that described the amount as “substantial.” Funds will support commercialization of a nanoLOCK surface interbody device, including a doubling of Titan’s salesforce.
In 2011, the company raised $2.6MM in Series B units from 12 investors.
Sources: Milwaukee BizTimes.com; ORTHOWORLD Inc.
Titan Spine raised US $7.5MM in Series D financing, alluded to in an earlier announcement that described the amount as "substantial." Funds will support commercialization of a nanoLOCK...
Titan Spine raised US $7.5MM in Series D financing, alluded to in an earlier announcement that described the amount as “substantial.” Funds will support commercialization of a nanoLOCK surface interbody device, including a doubling of Titan’s salesforce.
In 2011, the company raised $2.6MM in Series B units from 12 investors.
Sources: Milwaukee BizTimes.com; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
